Skip to content

Study · Not a test of the peptide alone · 2016

5 results

Elongator Plays a Positive Role in Exogenous NAD-Induced Defense Responses in Arabidopsis.

An C, Ding Y, Zhang X, Wang C, Mou Z

Molecular plant-microbe interactions : MPMI5 Apr 2016Cited by 14 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone5

In this study, NAD+ (nicotinamide adenine dinucleotide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking NAD+ (nicotinamide adenine dinucleotide).

  1. 01LabNot a test of NAD+ (nicotinamide adenine dinucleotide) aloneOther designMechanism

    In Arabidopsis, ELO3/AtELP3 mutations compromised NAD+-induced PR gene expression.

    In plain wordsIn lab tests, ELO3 mutations reduced NAD+-induced defense gene expression compared with plants without these mutations.

    Outcome
    DecreaseELO3 mutant PR gene expression
    Study

    Arabidopsisn: not reported in source

    Elongator mutant plants
    Comparator
    Plants without the reported mutation
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Mutations in the ELO3/AtELP3 gene compromise exogenous NAD(+)-induced expression of pathogenes

    In this study, NAD+ (nicotinamide adenine dinucleotide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking NAD+ (nicotinamide adenine dinucleotide).

  2. 02LabNot a test of NAD+ (nicotinamide adenine dinucleotide) aloneOther designMechanism

    In Arabidopsis, ELO3/AtELP3 mutations compromised NAD+-induced resistance to Pseudomonas syringae pv. maculicola ES4326.

    In plain wordsIn lab tests, ELO3 mutations reduced NAD+-induced bacterial resistance compared with plants without these mutations.

    Outcome
    DecreaseELO3 mutant bacterial resistance
    Study

    Arabidopsisn: not reported in source

    Elongator mutant plants
    Comparator
    Plants without the reported mutation
    Outcome group
    Infection and antimicrobial activity · Infection

    Source sentences

    Summary
    Mutations in the ELO3/AtELP3 gene compromise exogenous NAD(+)-induced expression of pathogenesis-related (PR) genes and resistance to the bacterial pathogen Pseudomonas syringae pv. maculicola ES4326

    In this study, NAD+ (nicotinamide adenine dinucleotide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking NAD+ (nicotinamide adenine dinucleotide).

  3. 03LabNot a test of NAD+ (nicotinamide adenine dinucleotide) aloneOther designMechanism

    In Arabidopsis mutants, transgenic ELO3/AtELP3 coding-region expression restored NAD+ responsiveness.

    In plain wordsIn lab tests, ELO3 gene expression restored NAD+ responsiveness compared with mutant plants.

    Outcome
    IncreaseTransgenic restoration of NAD responsiveness
    Study

    Arabidopsisn: not reported in source

    Elongator mutant plants
    Comparator
    elo3/Atelp3 mutant plants
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    transgenic expression of the coding region of ELO3/AtELP3 in elo3/Atelp3 restores NAD(+) responsiveness to the mutant plants

    In this study, NAD+ (nicotinamide adenine dinucleotide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking NAD+ (nicotinamide adenine dinucleotide).

  4. 04LabNot a test of NAD+ (nicotinamide adenine dinucleotide) aloneOther designMechanism

    In Arabidopsis, mutations in the other five Elongator subunit genes compromised NAD+-induced PR gene expression.

    In plain wordsIn lab tests, other Elongator gene mutations reduced NAD+-induced defense gene expression compared with plants without these mutations.

    Outcome
    DecreaseOther Elongator mutant PR gene expression
    Study

    Arabidopsisn: not reported in source

    Elongator mutant plants
    Comparator
    Plants without the reported mutation
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Furthermore, mutations in genes encoding the other five Arabidopsis Elongator subunits (ELO2/AtELP1, AtELP2, ELO1/AtELP4, AtELP5, and AtELP6) also compromise exogenous NAD(+)-induced PR gene expression and resistance to P. syringae pv. maculicola ES4326.

    In this study, NAD+ (nicotinamide adenine dinucleotide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking NAD+ (nicotinamide adenine dinucleotide).

  5. 05LabNot a test of NAD+ (nicotinamide adenine dinucleotide) aloneOther designMechanism

    In Arabidopsis, mutations in the other five Elongator subunit genes compromised NAD+-induced bacterial resistance.

    In plain wordsIn lab tests, other Elongator mutations reduced NAD+-induced bacterial resistance compared with plants without these mutations.

    Outcome
    DecreaseOther Elongator mutant bacterial resistance
    Study

    Arabidopsisn: not reported in source

    Elongator mutant plants
    Comparator
    Plants without the reported mutation
    Outcome group
    Infection and antimicrobial activity · Infection

    Source sentences

    Summary
    Furthermore, mutations in genes encoding the other five Arabidopsis Elongator subunits (ELO2/AtELP1, AtELP2, ELO1/AtELP4, AtELP5, and AtELP6) also compromise exogenous NAD(+)-induced PR gene expression and resistance to P. syringae pv. maculicola ES4326.

    In this study, NAD+ (nicotinamide adenine dinucleotide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking NAD+ (nicotinamide adenine dinucleotide).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.